Author: [AUTHOR] Published on 6/1/2020 12:00:00 AM

Yan Ji, PhD, Director, Novartis Pharmaceuticals, East Hanover, New Jersey

ASCPT membership has helped Dr. Ji learn new directions in the field and to broaden her views. She especially enjoys participating in the Annual Meeting and webinars. She also appreciates the ASCPT journal family and receiving US Food and Drug Administration (FDA) news in her inbox. All of these channels inform her about new scientific areas, and have provided her with insights and new ideas.

Dr. Ji has always had a strong interest in integrating quantitative science with experimental sciences. She received her PhD training in pharmacokinetics/pharmacodynamics and modeling and simulation, which matches with her academic interests. She then started working in the pharmaceutical industry to apply what she has learned. Over the years of her career, she has worked in different stages of drug development for various molecular modalities. Clinical pharmacology and transitional science has been one of her main focuses where pharmacokinetic/pharmacodynamic (PK/PD) and modeling and simulation can have impact.

Everday, Dr. Ji is doing her best to help develope better and safer medicines for patients, which is her ultimate goal. She is thankful for working in a unique field that integrates data from different disciplines to make informative decisions. Working with project teams, she has been able to use her expertise in clinical pharmacology and quantitative pharmacology to inform key decision making in clinical development, registration strategy, and label indication. She explains: “seeing my work make a difference in patients’ lives is very rewarding and keeps me motivated every single day.”

ASCPT is a leading organization in the field of clinical pharmacology and translational science. Dr. Ji believes that ASCPT’s emphasis on innovation has brought new ideas and trends in the area of clinical pharmacology and translational medicine. She thinks that ASCPT can further broaden this influence in innovative science. In addition, ASCPT can further strengthen the incluence in the medical field and engage more clinicians.

Attending Annual Meetings, webinars, joining Communities, and volunteering are vital to the younger generation interested in getting involved in ASCPT. She explains that there are many volunteer opportunities with the Society to which one can contribute. She believes that ASCPT has been very supportive of career development for early investigators and offers benefits like the Early Career Community and mentoring programs.

Dr. Ji has been a member of ASCPT since 2015. She serves as the Chair of the Oncology Community.